Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression changes caused by treatment of TPC1 cells with RET inhibitor BLU6864 [BLU6864_6H vs DMSO]

ABSTRACT: Gene expression changes caused by treatment of TPC1 cells with RET inhibitor BLU6864 [BLU6864_6H vs DMSO]

PROVIDER: PRJNA818026 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18390890_1.fastq.gz	Fastqsanger.gz
	SRR18390890_2.fastq.gz	Fastqsanger.gz
	SRR18390891_1.fastq.gz	Fastqsanger.gz
	SRR18390891_2.fastq.gz	Fastqsanger.gz
	SRR18390892_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Gene expression changes caused by treatment of TPC1 cells with RET, FGFR inhibitor

Project description:Gene expression changes caused by treatment of TPC1 cells with RET, FGFR inhibitor

| PRJNA818018 | ENA

Gene expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1

2014-06-30 | GSE49414 | GEO

microRNA expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1

2014-06-30 | GSE49401 | GEO

Gene expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1

Project description:We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. Gene expression changes were evaluated comparing cells treated with the inhibitor for 24 hours versus cells treated with DMSO for 24 hours. Biological triplicates for RPI-1 and DMSO treated cells were generated by independent treatments and total RNA extractions.

2014-06-30 | E-GEOD-49414 | biostudies-arrayexpress

microRNA expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1

Project description:We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. microRNA expression changes were evaluated comparing cells treated with the inhibitor fo 24 hours versus cells treated with DMSO for 24 hours. Biological triplicates for RPI-1 and DMSO treated cells were generated by independent treatments and total RNA extractions. One sample from each class did not pass quality control, and thus was discarded. The final dataset comprises two samples for each class.

2014-06-30 | E-GEOD-49401 | biostudies-arrayexpress

Gene expression changes caused by treatment of TPC1 cells with RET inhibitor BLU6864 from 6 to 24 hours [BLU6864_24H vs BLU6864_6H]

Project description:Gene expression changes caused by treatment of TPC1 cells with RET inhibitor BLU6864 from 6 to 24 hours [BLU6864_24H vs BLU6864_6H]

| PRJNA818801 | ENA

Gene expression changes caused by treatment of TPC1 cells with RET inhibitor BLU6864 [BLU6864_6H vs DMSO]

Project description:NOT PROVIDED; REQUESTED

2022-03-23 | GSE199021 | GEO

Gene expression changes caused by treatment of TPC1 cells with RET inhibitor BLU6864 in combination with FGFR inhibitor BGJ398 vs. BLU6864 alone [BGJ398_24H + BLU6864_24H vs BLU6864_24H]

Project description:Gene expression changes caused by treatment of TPC1 cells with RET inhibitor BLU6864 in combination with FGFR inhibitor BGJ398 vs. BLU6864 alone [BGJ398_24H + BLU6864_24H vs BLU6864_24H]

| PRJNA818024 | ENA

Gene expression changes caused by treatment of TPC1 cells with RET, FGFR inhibitor

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-03-23 | GSE199022 | GEO

Gene expression changes caused by treatment of TPC1 cells with FGFR inhibitor BGJ398 [BGJ398_6H and BGJ398_24H]

Project description:Gene expression changes caused by treatment of TPC1 cells with FGFR inhibitor BGJ398 [BGJ398_6H and BGJ398_24H]

| PRJNA818023 | ENA